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ABSTRACT
Insulin receptor substrate-2-deficient (IRS2−/−) mice are considered a
good model to study the development of diabetes because IRS
proteins mediate the pleiotropic effects of insulin-like growth factor-I
(IGF-I) and insulin on metabolism, mitogenesis and cell survival. The
hypothalamus might play a key role in the early onset of diabetes,
owing to its involvement in the control of glucose homeostasis and
energy balance. Because some inflammatorymarkers are elevated in
the hypothalamus of diabetic IRS2−/− mice, our aim was to analyze
whether the diabetes associated with the absence of IRS2 results in
hypothalamic injury and to analyze the intracellular mechanisms
involved. Only diabetic IRS2−/− mice showed increased cell death
and activation of caspase-8 and -3 in the hypothalamus. Regulators
of apoptosis such as FADD, Bcl-2, Bcl-xL and p53 were also
increased, whereas p-IκB and c-FLIPL were decreased. This was
accompanied by increased levels of Nox-4 and catalase, enzymes
involved in oxidative stress. In summary, the hypothalamus of
diabetic IRS2−/− mice showed an increase in oxidative stress and
inflammatory markers that finally resulted in cell death via substantial
activation of the extrinsic apoptotic pathway. Conversely, non-
diabetic IRS2−/− mice did not show cell death in the hypothalamus,
possibly owing to an increase in the levels of circulating IGF-I and in
the enhanced hypothalamic IGF-IR phosphorylation that would lead
to the stimulation of survival pathways. In conclusion, diabetes in
IRS2-deficient male mice is associated with increased oxidative
stress and apoptosis in the hypothalamus.
KEY WORDS: Diabetes, Cell death, IRS2, Apoptosis, Oxidative
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INTRODUCTION
Insulin receptor substrates (IRSs) mediate the pleiotropic effects of
insulin-like growth factor-I (IGF-I) and insulin on metabolism,
mitogenesis and cell survival. Upon activation of receptors for insulin
or IGF-I, phosphorylation of several IRSs occurs, leading to the
activation of major regulatory intracellular pathways involved in
proliferation and metabolism (White, 2014). Male IRS2-deficient
mice (IRS2−/−) are used as a type 2 diabetes model because they
exhibit defects in hepatic insulin signalling, resulting in impaired
suppression of glucose production (Withers et al., 1998; Kubota et al.,
2000; Previs et al., 2000), and β-cell failure due to disruption of the
IGF-I receptor (IGF-IR) mitogenic signalling (Withers et al., 1999)
and increased β-cell apoptosis (Lingohr et al., 2003). Furthermore,
IRS2-deficient mice recapitulate the fulminate onset of human
diabetes because a significant proportion of these mice develop
diabetes abruptly at 12-16 weeks of age (Hashimoto, 2011; Garcia-
Barrado et al., 2011). Also, IRS2-deficient mice show central leptin
resistance resulting in alterations in the control of neuropeptides in the
arcuate nucleus (Masaki et al., 2012). Interestingly, the magnitude of
glucose deregulation in IRS2-deficient mice can be variable, with
certain congenic strains only presenting prediabetic changes
(Hashimoto, 2011). This phenotypic divergence might allow an
experimental tool to analyze pathogenic factors involved in central
insulin signalling pathways leading to two different outcomes:
prediabetes or overt diabetes (Cai, 2012). In a previous study
(Burgos-Ramos et al., 2012), we found activation of hypothalamic
inflammatorypathways that differentially correlatewith the absence or
presence of diabetes in IRS2-deficient mice, suggesting that the
inflammatory process could be related to the onset of disease.
Induction of oxidative stress actively participates in tissue
damage caused by hypoglycaemia and diabetes, and results in
deterioration of glucose homeostasis (Singh et al., 2004). The
mechanisms and pathways involved in this process are complex. If
reactive oxygen species (ROS) are not detoxified, cellular
components are damaged and stress-sensitive intracellular
signalling pathways mediated by nuclear factor-kappa B (NFκB),
p38 and Jun N-terminal kinase [JNK; also known as stress-activated
kinases (SAPK)] are altered (Newsholme et al., 2007). Although the
brain consumes 20% of the oxygen in the body and has a high
content of unsaturated fatty acids and catecholamines that are readily
oxidized, it has a low content of antioxidants (Rizzo et al., 2010),
which makes it a susceptible organ to oxidative damage (Uttara
et al., 2009). Oxidation produces lipid peroxides and DNA oxides
that produce cell disturbances that lead to inflammation and
deterioration of the central nervous system. Multiple mechanisms
have been proposed to protect cells from apoptosis, including the
activation of insulin signalling mediators through IRS2, such as the
phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) (FrankeReceived 28 September 2015; Accepted 11 March 2016
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et al., 1997; Valverde et al., 2004) and Ras/mitogen-activated
protein kinases (MAPK) pathways (Schubert et al., 2004). Hence, in
the present study, we analyzed whether diabetes caused by IRS2
deficiency affects cell death in the hypothalamus, because this
neuroendocrine organ is a key target for inflammation and oxidative
stress in diabetes (Cai and Liu, 2011), and we analyzed the
mechanisms involved.
RESULTS
Cell death and apoptotic pathways in the hypothalamus of
non-diabetic and diabetic IRS2−/−mice
Cell death in the hypothalamus was quantified by ELISA. Only
diabetic IRS2−/− mice showed increased cell death [non-diabetic
(ND): 121%; diabetic (D): 211% of wild-type (WT) values,
Fig. 1A]. To determine the signalling pathways involved in
the observed cell death, activation of caspases was analyzed.
Activation of caspase-3, measured by bead array, was detected
in diabetic IRS2−/− mice (144% of WT values), but not in
non-diabetic IRS2−/−mice (99% ofWT values, Fig. 1B). Caspase-8
(initiator caspase of the extrinsic apoptotic pathway) and caspase-9
(initiator caspase of the intrinsic pathway) were measured by
western blotting. Levels of fragmented caspase-8 increased in
diabetic IRS2−/− mice (ND: 103%; D: 212% of WT values,
Fig. 1C); however, levels of fragmented caspase-9 did not change in
either group (Fig. 1D).
Taking into account these data, levels of TNF-related apoptosis-
inducing ligand (TRAIL) and Fas-associated death domain
(FADD), two proteins involved in the extrinsic pathway of
apoptosis, were assayed by western blotting. Levels of FADD
were increased in diabetic IRS2−/−mice (ND: 83%; D: 192% ofWT
values; Fig. 2A). By contrast, levels of TRAIL were not different in
diabetic and non-diabetic IRS2−/−mice (ND: 104% and D: 105% of
WT values, Fig. 2B).
Next, we studied the levels of the apoptosis inhibitory proteins
X-linked inhibitor of apoptosis (XIAP) and FADD-like IL-1β-
converting enzyme-inhibitory protein large (FLIP). Levels of XIAP
Fig. 1. Cell death and caspase activation in the hypothalamus of non-diabetic and diabetic IRS2−/− mice. Relative levels of cell death assayed
by ELISA (A), activated caspase-3 measured by bead array assay (B), caspase-8 and caspase-9 assayed by western blotting (C,D) in the hypothalamus of
wild-type (WT), non-diabetic IRS2-deficient (ND IRS2−/−) and diabetic IRS2-deficient (D IRS2−/−) mice. Data are presented as means±s.e.m. Statistical
significance by ANOVA: *P<0.05 and **P<0.01 vs WT mice; #P<0.05 and ##P<0.01 vs ND IRS2−/−; n=6/group.
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were not statistically different among groups (ND: 70%; D: 84%
of WT values, Fig. 2C), whereas diabetic IRS2−/− mice showed
decreased FLIPL levels compared to the controls (ND: 96%; D: 80%
of WT values, Fig. 2D).
Activation of NFκB was assayed by studying the levels
of phosphorylated IκB. In diabetic IRS2−/− mice, decreased
levels of phosphorylated IκB were found (ND: 90%; D: 47% of
WT value; Fig. 2E). In contrast, the mRNA levels ofNfkbiamRNA,
Fig. 2. Regulation of the extrinsic pathway of apoptosis in the hypothalamus of non-diabetic and diabetic IRS2−/− mice. Immunoblots probed with
antibodies towards Fas-associated death domain (FADD) (A), TRAIL (B), XIAP (C), FLIP (D), phosphorylate IκB (p-IκB) (E) and phosphorylate p53 (p-p53) and
p53 measured by bead array assay (F) in wild-type (WT), non-diabetic IRS2-deficient (ND IRS2−/−) and diabetic IRS2-deficient (D IRS2−/−) mice. Data are
presented as means±s.e.m. Statistical significance by ANOVA: *P<0.05 and **P<0.01 vs WT mice; #P<0.05 and ##P<0.01 vs ND IRS2−/−; n=6/group.
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which encodes IkBα, were increased in the hypothalamus of
diabetic IRS2−/− mice (ND: 117%; D 154% of WT value).
Moreover, levels of p53 increased in IRS2−/− mice, with this
increase being statistically significant only in diabetic mice (ND:
142%; D: 193% of WT mice; Fig. 2F).
Levels of the anti-apoptotic proteins Bcl-2 and Bcl-xL, and pro-
apoptotic proteins BAD, BID and BIM, were analyzed by western
blotting. Bcl-2 and Bcl-xL were increased in diabetic IRS2−/− mice
(185% and 141% of WT values, respectively) but did not change in
non-diabetic IRS2−/− mice (114% and 122% of WT values,
Fig. 3. Regulation of Bcl-2 family proteins in the hypothalamus of non-diabetic and diabetic IRS2−/− mice. Immunoblots probed with antibodies against
Bcl-2 (A), Bcl-xL (B), BAD (C), BID (D) and BIM (E) in the hypothalamus of wild-type (WT), non-diabetic IRS2-deficient (ND IRS2−/−) and diabetic IRS2-deficient
(D IRS2−/−) mice. (F) Representative immunoblotos for Bcl-2, Bcl-xL, BAD, BID, BIM andGAPDH. Data are presented asmeans±s.e.m. Statistical significance by
ANOVA: *P<0.05 vs WT mice; n=6/group.
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respectively; Fig. 3A,B). Levels of pro-apoptotic proteins did not
change in any IRS2−/− group regardless of diabetes: BAD (ND:
101%; D: 99% of WT values), truncated BID (t-BID)/BID (ND:
96%; D: 101% of WT values) and BIM (ND: 96%; D: 112% of WT
values; Fig. 3C,D and E, respectively).
To study the inflammatory state of the hypothalamus, we
measured the levels of several cytokines involved in the
inflammatory process. As shown in Table 1, TNF-α, IL-6 and
IL-1βwere increased in the hypothalamus of diabetic IRS2−/−mice,
whereas IL-10 was decreased although the latter did not reach
statistical significance. By contrast, non-diabetic IRS2−/− mice
showed reduced levels of IL-6.
Oxidative stress in the hypothalamus of non-diabetic and
diabetic IRS2−/−mice
To study the role of oxidative stress, different enzymes were
assessed. NADPH oxidase 4 (Nox-4) mRNA levels were increased
in diabetic IRS2−/− mice (ND: 93%; D: 157% of WT values,
Fig. 4A). Catalase protein levels, measured by western blotting,
were also increased in diabetic IRS2−/− mice (ND: 113%; D: 140%
of WT values; Fig. 4B).
Levels of glutathione reductase and malondialdehyde (MDA),
determined by western blotting, did not change in diabetic or non-
diabetic mice (glutathione reductase ND: 101%, D: 109% of WT
values; MDA: ND: 102%, D: 103% of WT values; Fig. 4C).
Table 1. Levels of several cytokines involved in the inflammatory
process
Cytokine WT ND IRS2−/− D IRS2−/−
TNF-α 1.7±0.2 1.1±0.4 3.2±0.1**
IL-6 6.4±0.3 0.8±0.1** 8.4±0.3**,##
IL-1β 25.6±1.7 16.8±4 30±4#
IL-10 17±2.6 22±5 11.4±2.4
Cytokine concentrations (pg/mg of protein) in the hypothalmus of WT, ND
IRS2−/− and D IRS2−/−mice. **P<0.01 vs WT mice; #P<0.05 and ##P<0.01 vs
ND IRS2−/−; n=6/group.
Fig. 4. Analysis of oxidative stress markers in the hypothalamus of non-diabetic and diabetic IRS2−/− mice. Relative mRNA levels of Nox-4 (A), and
immunoblots probed with antibodies against catalase (B), glutathione reductase (C) and malondialdehyde (MDA) (D) in the hypothalamus of wild-type (WT),
non-diabetic IRS2-deficient (ND IRS2−/−) and diabetic IRS2-deficient (D IRS2−/−) mice. Data are presented as means±s.e.m. Statistical significance by ANOVA:
*P<0.05 vs WT mice; #P<0.05 vs ND IRS2−/−. n=6/group.
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Identification of cell types susceptible to apoptosis in the
hypothalamus of IRS2−/−mice
We measured glial fibrillary acidic protein (GFAP) as a marker of
astrocytes and neuronal β-III tubulin (Tuj-1), as a marker of neurons,
by western blotting. Only diabetic IRS2−/− mice presented
decreased levels of GFAP (ND: 90%; D: 26% vs WT mice).
Levels of Tuj-1 were similar in all groups (ND: 84%; D: 101% vs
WT mice; Fig. 5A and B, respectively).
Fig. 5. Analysis of the cell type susceptible to apoptotic cell death in the hypothalamus of IRS2−/− mice. Immunoblots probed with antibodies against
GFAP (A) and Tuj-1 (B) in the hypothalamus of wild-type (WT), non-diabetic IRS2-deficient (ND IRS2−/−) and diabetic IRS2-deficient (D IRS2−/−) mice. The
average of three independent assays performed in duplicate is shown. Statistical significance by ANOVA: *P<0.05 vs WT mice. n=6/group. (C) Colocalization of
TUNEL and GFAP in the hypothalamus of WT, ND IRS2−/− and D IRS2−/− mice. Arrows indicate astrocytes with apoptotic nuclei. (D) Colocalization of cleaved
caspase-8 and GFAP, and of cleaved caspase-8 and NeuN, in the hypothalamus of WT, ND IRS2−/− and D IRS2−/−mice. Arrows indicate colocalization of GFAP
and cleaved caspase-8. Scale bar: 50 µm; inset, 100 µm.
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To determine whether astrocytes are the cells dying by apoptosis
in the hypothalamus of diabetic IRS2−/− mice, we performed
TUNEL assays in combination with immunofluorescence for GFAP
in cryostat brain sections. As shown in Fig. 5C, TUNEL signal was
increased in the hypothalamus of diabetic IRS2−/− mice. Moreover,
colocalization of TUNEL with GFAP was also observed in the
hypothalamus of diabetic IRS2−/− mice.
Analysis of cleaved caspase-8 localization in the
hypothalamus of non-diabetic and diabetic IRS2−/−mice
To establish the type of hypothalamic cell in which caspase-8 is
fragmented, brain slices were immunoassayed for cleaved caspase-8
in combination with GFAP or NeuN (a neuronal-specific antibody).
Inmunostaining for cleaved caspase-8 was scarce in the
hypothalamus of WT and non-diabetic IRS2−/− mice. By contrast,
cleaved caspase-8 expression increased in diabetic IRS2−/− mice
and colocalized mainly with GFAP (Fig. 5D).
Analysis of IGF-I and IGF-IR levels in the hypothalamus of
non-diabetic and diabetic IRS2−/−mice
We measured serum IGF-I levels by ELISA and observed an
increase in non-diabetic IRS2−/− mice as compared to the WT
controls (WT: 140 ng/ml; ND: 295 ng/ml; D: 153 ng/ml; Fig. 6A).
Moreover, the hypothalamic levels of phosphorylated IGF-IR were
increased in non-diabetic IRS2−/−mice (162% of WT), but IRS2−/−
diabetic mice showed levels of IGF-IR that were not different from
those of WT mice (83%; Fig. 6B).
DISCUSSION
The hyperglycaemia associated with diabetes causes cellular
dysfunction through various mechanisms and this can result in
tissue injury. Diabetic IRS2−/− mice are hyperglycaemic (Withers
et al., 1998, 1999; González-Rodríguez et al., 2010; Burgos-Ramos
et al., 2012) and hyperglycaemia itself activates NADPH oxidases
to accelerate oxidative stress (Koike et al., 2007), which is
considered an important mediator of diabetic complications
(Inoguchi et al., 2007). In order to study the role of oxidative
stress and the relationship with inflammatory processes described in
diabetes, we analyzed the levels of key enzymes involved in
oxidative stress in the hypothalamus of IRS2−/−mice and found that
protein levels of catalase were increased in diabetic IRS2−/− mice.
This effect could be attributed to higher levels of H2O2, reflected by
increased Nox-4 mRNA levels, because H2O2 is the major form of
ROS generated by this NADPH oxidase (Lambeth, 2007; Serrander
et al., 2007).
Oxidative stress induced by hyperglycaemia serves as a key
trigger of inflammatory gene expression (Gumieniczek et al., 2005).
Pro-inflammatory cytokines play an important role in the pathology
of diabetes (Bodles and Barger, 2004). TNF-α has been suggested
to participate in the development of diabetes by impairing insulin
actions (Lechleitner et al., 2000; Tuttle et al., 2004). TNF-α also
stimulates the production of ROS that directly signal cells to
undergo apoptosis (Kim et al., 2010). In this regard, we found
increased levels of cell death in the hypothalamus of diabetic
IRS2−/− mice, compared with non-diabetic IRS2−/− and WT mice,
that could be due to increased levels of pro-inflammatory cytokines
such as TNF-α, IL-6 and IL-1β. TNF-α could activate caspase-8,
involving the adaptor protein FADD (MORT1); this activation is
essential to bridge members of the TNF receptor (TNFR)
superfamily to procaspase-8 to assemble the death-inducing
signalling complex (DISC) during apoptosis (Micheau and
Tschopp, 2003). In turn, caspase-8 can then activate caspase-3,
although a direct pathway for caspase-8-elicited apoptosis has also
been described (Benchoua et al., 2002). The intrinsic and extrinsic
pathways are not completely independent. In fact, in some cells,
activation of caspase-8 results in the activation of the mitochondrial
pathway through the cleavage of the BH3-only proteins BIM, BID
and p53 up-regulated modulator of apoptosis (PUMA); this is
essential for the activation of the BAX- and BAK-dependent cell
death program (Ren et al., 2010; Favaloro et al., 2012). However,
our results showed that BIM and BID were not cleaved in the
hypothalamus of IRS2−/− mice, therefore excluding the
involvement of the intrinsic pathway in apoptosis. These results
were also supported by the lack of activation of caspase-9.
Other relevant proteins involved in apoptosis that have been
found to be upregulated in the hypothalamus of diabetic IRS2−/−
mice are the transcription factor p53 and NFκB. p53, a key factor in
apoptosis (Reinhardt and Schumacher, 2012), is activated in
response to oxidative stress and DNA damage induced by H2O2
(Han et al., 2008). Furthermore, the activation of caspase-8 has been
implicated in p53-mediated apoptosis (Haupt et al., 2003).
Hyperglycaemia has also been shown to activate p53, resulting in
cell death (Eid et al., 2010). In addition, TNF-α, which was elevated
in the serum and hypothalamus of diabetic IRS2−/− mice together
Fig. 6. IGF-I and IGF-IR levels.Serum levels of IGF-I assayed by ELISA (A) and relative levels of phosphorylated IGF-IR in the hypothalamusmeasured by bead
array assay (B) of wild-type (WT), non-diabetic IRS2-deficient (ND IRS2−/−) and diabetic IRS2-deficient (D IRS2−/−) mice. Data are presented as means±s.e.m.
Statistical significance by ANOVA: *P<0.05 and **P<0.01 vs WT mice; #P<0.05 and ##P<0.01 vs ND IRS2−/−; n=6/group.
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with IL-6 and IL-1β, could activate both caspase-8 and p53 in the
hypothalamus of diabetic IRS2−/− mice, and this activation could
explain the elevated cell death. On the other hand, NFκB has been
associated with the extrinsic cell-death pathway because it can be
activated by pro-apoptotic signals, including death receptors
(Dickens et al., 2012). However, NFκB has a dual role and can
also participate in cell survival (Morgan and Liu, 2011; Singh et al.,
2015) through the activation of inhibitors of apoptosis (IAPs) and
other survival proteins such as Bcl-2 and Bcl-xL (Dolcet et al.,
2005). Although there are a few exceptions, NFκB contributes to
cell death (Perkins and Gilmore, 2006) in most cases. In this regard,
various recent reports have shown that overexpression of NFκB
impairs survival, proliferation and differentiation of hypothalamic
neural stem cells, with an increase in apoptosis by induction of pro-
apoptotic members of Bcl-2 family and caspases and upregulation
of anti-apoptotic genes (Li et al., 2012). Therefore, the increased
levels of NFκB might be associated with activation of the extrinsic
cell-death pathway and contribute to the cell death found in the
hypothalamus of diabetic IRS2−/− mice, although further studies
directed to inhibit inflammatory mediators are necessary to
complete this issue. Moreover, the increase in pro-inflammatory
cytokines in the hypothalamus could lead to a decay of Nfkbia
mRNA levels, which encodes IkBα. The resulting loss of IkBα
could trigger the activation of hypothalamic NFκB, which in turn
might be responsible for the inflammatory changes (Yan et al.,
2014). However, we found increased Nfkbia mRNA levels in
diabetic IRS2−/−mice, with overexpression of p65-NFκB that could
increase the transcription of Nfkbia mRNA in an auto-regulatory
loop, ensuring that NFκB is retained in the cytoplasm until cells are
specifically induced to translocate it to the nucleus (Scott et al.,
1993). Our results suggest that the IkBα feedback could be
dependent on NFκB but other processes dependent on the
molecular characteristics of the protein itself are probably
involved; for example, import, export and modulation of half-life
(Fagerlund et al., 2016).
One of the main signalling pathways that intersects with NFκB
with regards to ROS and cell death is the crosstalk that occurs
between NFκB and JNK (Morgan et al., 2008). As previously
reported (Burgos-Ramos et al., 2012), levels of JNK are higher in
the hypothalamus of diabetic IRS2−/−mice and phosphorylated IκB
is downregulated. Furthermore, NFκB and p53 transcriptionally
regulate the c-FLIP gene. A decrease in c-FLIPL was observed in the
hypothalamus of diabetic IRS2−/− mice. The anti-apoptotic protein
c-FLIP contains a death effector domain (DED) and suppresses
caspase-8 activation, preventing apoptotic processes (Safa, 2012).
Whereas NFκB suppresses c-FLIP transcription (Safa et al., 2008;
Bagnoli et al., 2010), p53 might induce c-FLIP gene transcription
and c-FLIP degradation (Safa and Pollok, 2011). c-FLIPL possesses
dual functions: at high levels it can inhibit the activation of caspase-
8 induced by Fas, but at low levels it enhances caspase-8 activation
(Safa et al., 2008; Bagnoli et al., 2010) as observed in the
hypothalamus of diabetic IRS2−/− mice. On the other hand, H2O2,
which is the most diffusible ROS, decreases c-FLIP expression in a
dose-dependent manner (Nitobe et al., 2003). Based on this,
downregulation of c-FLIP could be one possible mechanism by
which the hypothalamus of diabetic IRS2−/− mice is prone to
apoptosis.
To determine which population of cells is dying in the
hypothalamus of diabetic IRS2−/− mice, we measured GFAP and
Tuj-1 as markers of astrocytes and neurons, respectively. We found
that only diabetic IRS2−/− mice showed decreased levels of GFAP.
On the other hand, levels of Tuj-1 were similar in all groups.
TUNEL assays in combination with immunofluorescence for
GFAP confirmed that astrocytes were dying by apoptosis in
the hypothalamus of diabetic IRS2−/− mice. Likewise, activated
caspase-8 was also colocalized mainly with GFAP in the
hypothalamus of diabetic IRS2−/− mice. Previous studies in rats
have demonstrated that caspase-8 is present in the brain, particularly
in neurons and astrocytes, and plays a key role in the apoptotic cell
death response after injury (Villapol et al., 2007). Of note, because
cell death is a continuous process, cells can be found in different
stages. Astrocytes with active caspase-8 are probably at an early
process of apoptosis.
Insulin-like peptides are neuroprotective and might be involved
in the pathophysiology of a number of neurological diseases,
representing possible therapeutic objectives for these disorders
(Benarroch, 2012; Werner and LeRoith, 2014). In particular, IGF-I
exerts anti-apoptotic/pro-survival actions in a variety of systems,
including the brain (Guan et al., 2015). Furthermore, IGF-I is a
potent neuroprotective agent and also protects against oxidative
stress induced by the lipid-peroxidizing agent H2O2 (Heck et al.,
1999). The activation of the insulin receptor or IGF-IR transduces
their biological effects by tyrosine phosphorylation of IRSs and Src
homology 2 domain containing (Shc), and this, in turn, initiates a
signalling cascade through the PI3K/Akt and Ras/MAPK kinase
pathways (Siddle, 2011). Additionally, IGF-I mediates the
neuroprotection exerted by some substances by augmenting the
levels of anti-apoptotic proteins such as Bcl-2 and decreasing
the levels of the pro-apoptotic protein BAX and the activation of
caspases (Jiang et al., 2015). Non-diabetic IRS2−/− mice did not
manifest an increase in cell death in the hypothalamus, which could
possibly be due to the increased levels of circulating IGF-I and the
enhanced phosphorylation of the IGF-IR that would lead to the
activation of survival pathways through ERK and Akt as previously
reported (Burgos-Ramos et al., 2011), although further studies
would be necessary to clearly demonstrate this issue.
In summary, our findings suggest that the diabetic condition in
IRS2−/− mice entails an increase in oxidative stress and
inflammation in the hypothalamus that finally could result in cell
death via activation of the extrinsic apoptotic pathway. By contrast,
non-diabetic IRS2−/− mice did not show increased hypothalamic
cell death, possibly owing to the rise in circulating IGF-I levels and
IGF-IR phosphorylation, which would lead to stimulation of
survival pathways (summarized in Fig. 7). Hence, the exposure to
an inflammatory and oxidative milieu results in a diabetic-induced
hypothalamic injury in this model.
MATERIALS AND METHODS
Materials
Electrophoresis reagents were from Bio-Rad Laboratories (Hercules, CA)
and the rest of the chemicals and reagents were purchased from Sigma or
Merck (Barcelona, Spain) unless otherwise indicated.
Animals
All procedures were carried out in accordance with the local ethics
committee and complied with Royal Decree 53/2013 pertaining to the
protection of experimental animals and with the European Communities
Council Directive (2010/63/EU).
Wild-type (WT) and IRS2−/−mice, maintained on a similar mixed genetic
background (C57BL/6×129sv), were purchased from the Jackson
Laboratory (Bar Harbor, ME). Adult (11- to 12-week-old) male mice
were housed individually and maintained in a ventilated room at a constant
temperature (22°C) and humidity (50%) with free access to standard chow
and water on a 12-h light/dark cycle. In this study, we grouped mice in: WT
mice as controls, diabetic IRS2−/− (D IRS2−/−) with non-fasting glucose
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levels over 500 mg/dl (determined by the glucose oxidase method by using
the Precision G glucose meter; Abbott Laboratories, North Chicago, IL),
and age-matched non-diabetic IRS2−/− mice (ND IRS2−/−) with glucose
levels under 200 mg/dl (n=6 in each group). At 6-7 days after the debut of
diabetes, animals were sacrificed by decapitation at 10:00 a.m. under non-
fasting conditions. Mice from the control and ND IRS2−/− groups were
sacrificed at the same time as the D IRS2−/−mice. Trunk bloodwas collected
in cooled tubes and centrifuged at 3000 g for 10 min at 4°C. The serum was
stored at −80°C until processed.
Protein extraction and quantification
The hypothalami were homogenized on ice in 250 μl of lysis buffer (pH 7.6)
containing EDTA (10 mM), HEPES 50 (mM), sodium pyrophosphate
(50 mM), NaF (0.1 M), Na3VO4 (10 mM), 1% Triton X-100,
phenylmethylsulfonyl fluoride (2 mM), leupeptin (10 µg/ml) and
aprotinin (10 µg/ml). The lysates were incubated overnight at −80°C and
then clarified by centrifugation at 12,000 g for 5 min at 4°C. The
supernatants were transferred to fresh tubes and stored at −80°C until
assayed. Total protein concentration was determined by the method of
Bradford (Bio-Rad).
Western blot
A total of 40 µg of protein was loaded in all wells and resolved using an
8-12% SDS-PAGE and then transferred onto polyvinyl difluoride (PVDF)
membranes (Bio-Rad). Filters were blocked with Tris-buffered saline
containing 0.1% Tween 20 (TTBS) with 5% (w/v) bovine serum albumin
(BSA) or non-fat milk during 2 h at 25°C and incubated overnight at 4°C
with the primary antibody at a dilution of 1:1000 in blocking buffer. Primary
antibodies included: phosphorylated IκB from Cell Signaling Technology
(Danvers, MA); BAD and glutathione reductase from Santa Cruz
Biotechnology Inc. (Santa Cruz, CA); anti-FADD (M033-3; Clone 1F7)
and caspase-9 from MBL International (Woburn, MA); caspase-8 from
Neomarkers (Fremont, CA); TRAIL, Bcl-2, BID and β-III tubulin (Tuj-1)
from R&D Systems (Minneapolis, MN); XIAP and Bcl-xL from BD
Transduction Laboratories (Franklin Lakes, NJ); FLIP, catalase and GFAP
from Sigma-Aldrich (St Louis, MO), BIM from BD Pharmingen
(Mississauga, ON, Canada), and malondialdehyde from Cell Biolabs (San
Diego, CA). The membranes were washed three times with TTBS and
incubated with the corresponding secondary antibody conjugated with
peroxidase (Thermo Fisher Scientific Inc., Waltham, MA) at a dilution of
1:2000 in non-fat milk during 90 min at 25°C. The proteins were detected by
chemiluminescence using an immune-star western chemiluminiscent kit
(Bio-Rad) and quantified by densitometry using a Kodak Gel Logic 1500
Image Analysis system and Molecular Imaging Software version 4.0
(Rochester, NY). All blots were re-blotted with anti-glyceraldehyde-3-
phosphate dehydrogenase (GAPDH, AnaSpec, San Jose, CA) to normalize
for gel-loading variability.
Bead array assay
The content of TNF-α, IL-6, IL-1β, IL-10 and phosphorylated and total p53
and IGF-IR were measured by using a bead array assay (Merck Millipore,
Darmstadt, Germany) as previously described (Khan et al., 2004). Briefly,
beads conjugated to antibodyand lysates (50 μl each)were incubated for 18 h
at 25°C, washed and incubated with biotin-conjugated antibody (25 μl) for
30 min. Then the beads were incubated with 50 μl streptavidin conjugated
to phycoerythrin (PE) (streptavidin-PE, diluted 1:100) for 30 min.
Fluorescence was analyzed using a Bio-Plex suspension array system 200
(Bio-Rad Laboratories). Raw data [mean fluorescence intensity (MFI)] were
analyzed using the Bio-Plex Manager software 4.1 (Bio-Rad Laboratories).
For caspase-3 determination, 100 μg of protein and beads were incubated at
700 rpm for 2 h at 25°C,washed and posterior incubations performed for 1 h.
RNA purification
Total RNA was extracted following the instructions of TriReagent
(Invitrogen, Carlsbad, CA). Briefly, each hypothalamus was homogenized
in 1 ml of TriReagent and incubated for 5 min at room temperature (RT) to
dissociate nucleoprotein complexes. Chloroform (0.2 ml) was added and
samples were vortexed, incubated for 15 min at RT and then centrifuged at
12,000 g for 15 min at 4°C. The aqueous phase was transferred to new tubes
and isopropanol (0.5 ml) was added to precipitate RNA. Samples were
incubated for 10 min at RT and then centrifuged at 12,000 g for 10 min at
4°C. Pellets were washed in 75% ethanol (1 ml), centrifuged at 7500 g for
5 min at 4°C, and dissolved in RNase-free water. Absorbance at 260 nmwas
measured to determine concentrations.
Fig. 7. Graphical summary. Diagram representing the mechanism proposed for activation of cell death in astrocytes of diabetic IRS2−/− (D IRS2−/−) mice in the
hypothalamus (A) or inhibition of cell death in the hypothalamic astrocytes of non-diabetic IRS2−/− (ND IRS2−/−) mice in the hypothalamus (B).
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Reverse transcription (RT) and real-time RT-PCR
The reverse transcription reaction was performed on 2 μg of total RNA
using the high-capacity cDNA kit (Applied Biosystems, Foster City, CA).
Real-time RT-PCR was performed in an ABI Prism 7000 Sequence
Detection System (Applied Biosystems). Nfkbia mRNA levels were
measured using the TaqMan gene expression assay (Mm00477798_m1;
Applied Biosystems). The PCR mixture contained 300 nM of each primer.
Relative gene expression comparisons were carried out using an invariant
endogenous control (GAPDH). Nox-4 mRNA levels were measured with
SYBR Green (Roche, Mannheim, Germany), with primers purchased from
Sigma. The forward and reverse sequences were the following: 5′-TCCA-
AGCTCATTTCCCACAG-3′ and 5′-CGGAGTTCCATTACATCAGAGG-
3. The PCR mixture contained 300 nM of each primer. Relative gene exp-
ression comparisons were carried out using an invariant endogenous control
(GAPDH; 4352339E). According to the manufacturer’s guidelines, the
ΔΔCT method was used for relative quantification.
Immunoenzymometric assay (IEMA) for determination of IGF-I in
serum
The quantitative determination of serum IGF-I was performed with the
OCTEIA immunoenzymometric assay from IDS, Immunodiagnostic
Systems Limited (Boldon, Tyne and Wear, UK). The method was
performed according to the manufacturer’s instructions. Briefly, serum
samples were incubated with a reagent to inactivate binding proteins
(10 min) and then diluted for assay. Samples were added to antibody-coated
wells for 2 h, at RT on a shaking platform. The wells were washed and
horseradish peroxidase was added (30 min, RT); after washing, a solution of
tetra-methyl-benzidine was added to develop colour (30 min, RT). The
reaction was stopped and the absorbance read (450 nm; reference 650 nm) in
a microtiter plate reader (Tecan Infinite M200, Grödig, Austria), with colour
intensity being directly proportional to the amount of rat IGF-I present in the
sample. This assay has a sensitivity limit of 63 ng/ml. The intra- and inter-
assay coefficients of variation were 4.3% and 6.3%, respectively.
Cell death detection ELISA
This assay was carried out according to the manufacturer’s instructions
(Roche). Briefly, tissue was homogenized in incubation buffer and
microtiter plates were coated with anti-histone antibody. The samples
were added (in duplicate) and incubated (90 min, RT). The wells were then
washed and incubated with anti-DNA-peroxidase (90 min, RT). After
washing, substrate solution was added until the colour developed adequately
(approximately 15 min). The samples were measured at 405 nm on an
automatic microplate analyzer (Tecan Infinite M200, Grödig, Austria).
Background measurements at 490 nm were made and this value subtracted
from the mean value of each sample.
TUNEL plus immunohistochemistry
Cell death detection by TUNEL assay was performed following the
manufacturer’s instructions (Roche). Brieﬂy, after ﬁxation in 4%
paraformaldehyde in 0.1 M phosphate buffer (pH 7.4), cryostat brain
sections (20 µM) werewashed three times in phosphate buffer and incubated
for 30 min with a 0.1% sodium citrate, 0.1% Triton X-100 solution to
increase tissue permeability. Slides were again washed, and incubated with
TUNEL solution for 90 min at 37°C in a humid chamber in the dark. After
washing, the slides were incubated with an anti-GFAP antibody (1:2000), in
TBS containing 3% BSA and 1% Triton X-100 and left for 48 h at 4°C. The
slides were incubated with Alexa Fluor anti-ﬂuorescein-488 and -633-
conjugated goat anti-mouse IgG (1:2000;Molecular Probes, Eugene, OR) in
blocking buffer, both at a dilution of 1:1000. Finally, after washing, the
slides were mounted in Clear Mount (Electronic Microscopy Sciences,
Hartfield, PA). Immunofluorescence was visualized directly by using a DM
IRB confocal microscope (Leica, Wetzlar, Germany).
Immunofluorescence
Double-immunofluorescence for GFAP and active caspase-8 (Novus
Biologicals Europe, Cambridge, UK) or NeuN (Merck Millipore) and
active caspase-8 were carried out on sections (30 µm) obtained on a
vibratome. Sections were blocked in phosphate buffer 0.1 M pH 7.4
containing 3% BSA, 1% Triton X-100 for 24 h at 4°C. Afterwards, sections
were incubated with anti-GFAP (1:500) or anti-NeuN (1:500) and anti-
active capase-8 (1:500) diluted in blocking buffer for 48 h at 4°C. Sections
were then washed with phosphate buffer (PB) with 0.1% Triton X-100 and
incubated for 90 min at RT with anti-rabbit IgG-biotin (1:1000; Thermo
Scientific) diluted in blocking buffer, washed and incubated with
streptavidin Alexa Fluor 488 (1:1000, Molecular Probes) and Alexa Fluor
633 anti-mouse IgG (1:1000) for 90 min at RT. After washing, sections were
cover-slipped with Clear Mount. Immunofluorescence was visualized
directly by using a DM IRB confocal microscope.
Statistical analysis
All results are presented as mean±s.e.m. Statistical analysis of all data was
carried out by one-way ANOVA followed by a Bonferroni’s test. The values
were considered significantly different when the P-value was less than 0.05.
Statistical analyses were performed using Prisma software 4.0 (Prisma,
GraphPad, San Diego, CA).
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Nutrición.
References
Bagnoli, M., Canevari, S. and Mezzanzanica, D. (2010). Cellular FLICE-inhibitory
protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in
physiologic context and in cancer. Int. J. Biochem. Cell Biol. 42, 210-213.
Benarroch, E. E. (2012). Insulin-like growth factors in the brain and their potential
clinical implications. Neurology 79, 2148-2153.
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